During the last session, Oscar Health Inc (NYSE:OSCR)’s traded shares were 3.54 million, with the beta value of the company hitting 1.62. At the end of the trading day, the stock’s price was $17.04, reflecting an intraday gain of 6.97% or $1.11. The 52-week high for the OSCR share is $23.79, that puts it down -39.61 from that peak though still a striking 72.3% gain since the share price plummeted to a 52-week low of $4.72. The company’s market capitalization is $4.12B, and the average intraday trading volume over the past 10 days was 3.15 million shares, and the average trade volume was 2.96 million shares over the past three months.
Oscar Health Inc (OSCR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.86. OSCR has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oscar Health Inc (NYSE:OSCR) trade information
Oscar Health Inc (OSCR) registered a 6.97% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 6.97% in intraday trading to $17.04, hitting a weekly high. The stock’s 5-day price performance is 6.90%, and it has moved by -17.40% in 30 days. Based on these gigs, the overall price performance for the year is 247.76%. The short interest in Oscar Health Inc (NYSE:OSCR) is 12.37 million shares and it means that shorts have 4.28 day(s) to cover.
The consensus price target of analysts on Wall Street is $21, which implies an increase of 18.86% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $28 respectively. As a result, OSCR is trading at a discount of -64.32% off the target high and 70.66% off the low.
Oscar Health Inc (OSCR) estimates and forecasts
Statistics show that Oscar Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Oscar Health Inc (OSCR) shares have gone down -1.84% during the last six months, with a year-to-date growth rate more than the industry average at 100.82% against 11.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -2.85%. While earnings are projected to return 105.05% in 2024, the next five years will return 71.00% per annum.
OSCR Dividends
Oscar Health Inc is due to release its next quarterly earnings in November. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Oscar Health Inc (NYSE:OSCR)’s Major holders
Oscar Health Inc insiders own 2.82% of total outstanding shares while institutional holders control 86.85%, with the float percentage being 89.37%. VANGUARD GROUP INC is the largest shareholder of the company, while 367.0 institutions own stock in it. As of 2024-06-30, the company held over 17.38 million shares (or 7.5114% of all shares), a total value of $275.03 million in shares.
The next largest institutional holding, with 14.18 million shares, is of BLACKROCK INC.’s that is approximately 6.1246% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $224.25 million.
